Inventor · disambiguated record
Sasson Cohen
Also filed as: COHEN SASSON
15 granted patents·4 pending applications·467 citations·filing 1975–2004
94Inventor score
Top patents by PatentIndex Score
19 records- 0195US6528685B2Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Mar 4, 2003·47 cites·25 claims
- 0295US5914349ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Jun 22, 1999·50 cites·18 claims
- 0395US5877221ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 2, 1999·52 cites·29 claims
- 0494US5994408ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Nov 30, 1999·54 cites·32 claims
- 0586US6277886B1Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindanTEVA PHARMA·Filed 1999·Granted Aug 21, 2001·66 cites·21 claims
- 0686US5840756APharmaceutical composition of L-DOPA esterTEVA PHARMA·Filed 1996·Granted Nov 24, 1998·98 cites·16 claims
- 0782US5565462AComposition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivativeTEVA PHARMA·Filed 1994·Granted Oct 15, 1996·64 cites·4 claims
- 0871US4104397ASpiro (1,3-dioxolane-4,3') quinuclidine compoundsPURDUE FREDERICK CO·Filed 1976·Granted Aug 1, 1978·10 cites·8 claims
- 0967US4083985A6-Oxa-1-aza tricyclo dodecan-5-ones as psychomotor stimulatorsPURDUE FREDERICK CO·Filed 1976·Granted Apr 11, 1978·8 cites·15 claims
- 1062US6737547B1Compositions containing and methods of using N-acyl-1H-aminoindenesTEVA PHARMA·Filed 1999·Granted May 18, 2004·9 cites·35 claims
- 1156US4112082APharmaceutical composition for treating glaucoma and compound 1,3,2-dioxaphospheringnesISRAEL STATE·Filed 1975·Granted Sep 5, 1978·5 cites·9 claims
- 1252US2004175423A1Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compoundsFiled 2004·Application pending·0 cites
- 1351US2004176463A1Immediate release formulation of n-(2-propylpentanoyl)glycinamideFiled 2004·Application pending·0 cites
- 1447US4226996ANovel heterocyclic compounds and pharmaceutical composition containing themPURDUE FREDERICK CO·Filed 1978·Granted Oct 7, 1980·1 cites·2 claims
- 1547US4183938A1,8-Ethano-5-oxo-octa- and -decahydroquinolines and mydriatic compositions thereofPURDUE FREDERICK CO·Filed 1977·Granted Jan 15, 1980·1 cites·5 claims
- 1641US2003147957A1Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release coreFiled 2002·Application pending·0 cites
- 1738US4309544APreparation of 6-oxa-1-azatricyclo(6.2.2.02,7)dodecane-5-onesPURDUE FREDERICK CO·Filed 1979·Granted Jan 5, 1982·0 cites·2 claims
- 1833US2003152628A1Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release coreFiled 2002·Application pending·0 cites
- 1921US4146628AAntiarrhythmic quinuclidine carboxylic acid xylidide and method of producing the same and similar compoundsOPPENHEIMER EDNA·Filed 1977·Granted Mar 27, 1979·2 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Sasson Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →